Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation
Clinical trial NCT03486496 · UNKNOWN
Trial details
- NCT number
- NCT03486496
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-05
- Primary completion
- 2019-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.